[ad_1]
Jakarta, CNBC Indonesia – PT Bio Farma (Persero) emphasized that the age range that can participate in the massive Covid-19 vaccination next year is not limited to the age range of 18 to 59 years. People 60 and older can also participate, but they depend on the results of clinical trials of 3 vaccines that are still ongoing.
The director of Bio Farma Honesti Basyir said that the CoronaVac vaccine from Sinovac Biotech Ltd. not only clinically tested in Indonesia, but also in other countries such as Brazil. In that country, research subjects with ages up to 60 years are also used. Later there will be an information exchange with Brazil to see how the vaccine will work.
“The age range of 18 to 59 years does not mean that abroad is not allowed. Why? Because the Sinovac program is not only being tested in Indonesia, in Brazil some people are using it at the age of 60 Later we will also use that data and communicate with the POM. “Honesti said in Committee IX of the House of Representatives, on Monday (8/31/2020).
On the same occasion, he explained, Bio Farma has also received a commitment from Sinovac Biotech Ltd. for 210 million active ingredients / bulk vaccine for Covid-19, CoronaVac for the company. So for immunization needs, at least Indonesia has committed to procuring 260 million dose vaccines.
In the first stage, Indonesia will only receive 50 million in bulk from November 2020 to March 2021. This amount is expected to be spent until March 2021. Regarding the needs from April to December 2021, the company promised to distribute 210 million doses of vaccine to Indonesia.
“From April to December 2021, we need Sinovac’s commitment of 210 million doses of vaccine. So we can secure 260 million because then 130 people will schedule it, where 1 person 2 doses, 2 injections in the community, that’s 260 million for the community, “he said.
[Gambas:Video CNBC](Hello Hello)
